Rx Adherence Claims For Ribasphere RibaPak Sent Packing
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA tells Kadmon Pharmaceuticals that it can’t promote convenience advantages, however factual, as clinical benefits without adequate and well-controlled studies.